EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC 4.0

Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry

Antros Louca iD, Joakim Sundström iD, Araz Rawshani, Henrik Hagström, Magnus Settergren, Stefan James iD, Sasha Koul, Kristofer Skoglund, Dan Ioanes, Sebastian Völz, Anna Myredal, Oskar Angerås iD und 2 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70073 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Antros Louca und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Heart Valve Prosthesis, Bicuspid Aortic Valve Disease, Aortic Valve. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: A.L. has received funds through the Gothenburg Society of Medicine (1000894 and 1021054). T.R. has received funds through the Swedish Heart and Lung Foundation….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with bicuspid aortic valve (BAV) stenosis, but there is limited comparative data on balloon‐expandable (BEV) versus self‐expanding valves (SEV) in this population.

Aim

To compare clinical and hemodynamic outcomes between BEVs and SEVs in patients with BAV stenosis.

Methods

This observational cohort included all patients who underwent TAVR in Sweden between 2016 and 2022. Exclusion criteria included procedures for pure aortic insufficiency and valve‐in‐valve interventions. The analysis focused on Evolut, Sapien, Acurate, and Portico/Navitor valve families. A doubly robust approach was applied combining inverse probability of treatment weighting and multivariable regression. Sensitivity analyses were also conducted.

Results

Of 577 patients, 274 (47.5%) received a BEV. The majority in the SEV group received an Evolut valve (62%). The mean EUROSCORE II‐predicted mortality risk was 4.1% for BEV and 3.6% for SEV. BEVs were used more in patients with reduced ejection fraction (EF ≤ 40%) and larger aortic annuli. There were no significant differences between groups in periprocedural mortality, all‐cause mortality at a median follow‐up of 675 days, or device success. However, SEVs had higher technical success (aOR: 2.21, p = 0.006), lower postprocedural gradients (adjusted coefficient: −3.72, p < 0.001), and reduced risk of prosthesis‐patient mismatch (aOR: 0.10, p = 0.02). SEVs, though, had a higher incidence of paravalvular leakage (aOR: 7.5, p < 0.01).

Conclusion

Both BEVs and SEVs were feasible with similar clinical outcomes in BAV stenosis. SEVs had better hemodynamic outcomes but more paravalvular leakage. Randomized trials are needed to determine the optimal valve choice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisHeart Valve ProsthesisBicuspid Aortic Valve DiseaseAortic ValveTranscatheter Aortic Valve ReplacementBalloon ValvuloplastyHumansMaleRegistriesFemaleTreatment OutcomeProsthesis DesignAgedTime FactorsHemodynamicsAged, 80 and overRisk FactorsSwedenRecovery of FunctionRisk Assessment

Stichwörter der Autor:innen

aortic valve stenosisballoon expandable valvesbicuspid aortic valveself‐expanding valvestranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Heart Centre, Umeå University Hospital, Umeå, Sweden.
  • Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Department of Cardiology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
  • Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Antros Louca, Joakim Sundström, Stefan James, Oskar Angerås

Förderung

  • A.L. has received funds through the Gothenburg Society of Medicine (1000894 and 1021054). T.R. has received funds through the Swedish Heart and Lung Foundation…

Zitieren

APA

Louca, A., Sundström, J., Rawshani, A., Hagström, H., Settergren, M., James, S., Koul, S., Skoglund, K., Ioanes, D., Völz, S., Myredal, A., Angerås, O., Petursson, P., & Råmunddal, T. (2025). Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70073

Vancouver

Louca A, Sundström J, Rawshani A, Hagström H, Settergren M, James S, et al. Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70073

BibTeX
@article{Louca2025,
  author = {Louca, Antros and Sundström, Joakim and Rawshani, Araz and Hagström, Henrik and Settergren, Magnus and James, Stefan and Koul, Sasha and Skoglund, Kristofer and Ioanes, Dan and Völz, Sebastian and Myredal, Anna and Angerås, Oskar and Petursson, Petur and Råmunddal, Truls},
  title = {Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70073}
}
Kostenlos starten →